Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
444 items

Four in 10 US Adults Are at High Risk for Vision Loss

In 2017, approximately 93 million US adults aged 18 years or older, or about 4 in 10, were at high risk for vision loss, according to a new study published in JAMA Ophthalmology.
A fundus image

AI may help spot newborns at risk for most severe form of blinding disease

An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP.
Schematic showing how to produce iPS cells

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace and repair dying cells in retina

Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration.
NIH National Eye Institute logo

NEI seeks public comment on future research goals

As the year 2020 approaches, the National Eye Institute (NEI) is developing new plans for vision research over the coming decade.
Girl reading book, with hand over one eye

Treatment for common vision disorder does not improve children’s reading skills

Results from a clinical trial funded by the National Eye Institute (NEI) show that while vision therapy can successfully treat convergence insufficiency (CI) in children, it fails to improve their reading test scores.
eye anatomy graphic

Two commonly used uveitis drugs perform similarly in NIH-funded clinical trial

Methotrexate and the more expensive mycophenolate mofetil performed similarly in a head-to-head clinical trial that compared the two drugs for treating noninfectious uveitis, an eye disease that accounts for up to 15% of blindness in the U. S.
Diagram of RPE cell loss

Report: Dry AMD requires broad, systems biology approach leveraging big data, multiple disciplines

A large-scale, collaborative, systems biology approach is needed to expedite the discovery of treatments for dry age-related macular degeneration (AMD) – a leading cause of blindness among people 65 and older for which is there is no treatment.
7 men look at the camera in a group portrait

NEI Researchers Awarded Grants by the Knights Templar Eye Foundation

The Knights Templar Eye Foundation has awarded two NEI scientists grants to research inherited retinal degenerations, diseases that can cause blindness in early childhood.
color blindness comparison

Rosy Health and Sickly Green: Color Associations Play Robust Role in Reading Faces

Anyone who has ever sensed that a person is sick simply by looking at their face has experienced the wealth of information conveyed by face color.
Microglia in retinal sections of a patient with retinitis pigmentosa

Immune System Can Slow Degenerative Eye Disease, NIH-led Mouse Study Shows

A new study shows that the complement system, part of the innate immune system, plays a protective role to slow retinal degeneration in a mouse model of retinitis pigmentosa, an inherited eye disease.

Want more news from NEI?

Connect with us through social media to stay up to date on vision research, eye health, and other topics!

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248